Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

517 results about "Genomics" patented technology

Genomics is an interdisciplinary field of biology focusing on the structure, function, evolution, mapping, and editing of genomes. A genome is an organism's complete set of DNA, including all of its genes. In contrast to genetics, which refers to the study of individual genes and their roles in inheritance, genomics aims at the collective characterization and quantification of all of an organism's genes, their interrelations and influence on the organism. Genes may direct the production of proteins with the assistance of enzymes and messenger molecules. In turn, proteins make up body structures such as organs and tissues as well as control chemical reactions and carry signals between cells. Genomics also involves the sequencing and analysis of genomes through uses of high throughput DNA sequencing and bioinformatics to assemble and analyze the function and structure of entire genomes. Advances in genomics have triggered a revolution in discovery-based research and systems biology to facilitate understanding of even the most complex biological systems such as the brain.

Risk assessment system for chronic diseases

The invention relates to the technical field of medical data processing, in particular to a risk assessment system for chronic diseases. The system is used for performing physiological index analysis according to a medical physiological monitoring signal to generate physiological index data; performing individual physiological index weight empowerment on the physiological index data based on genomics data to obtain individual physiological index data; performing quantitative analysis on pathological influence factors of chronic disease types according to the electronic health record data and the individual physiological index data, and generating individual chronic disease influence factor quantitative data; performing composite interaction risk factor analysis on the individual chronic disease influence factors based on the quantitative data of the individual chronic disease influence factors to generate individual chronic disease composite interaction risk factor data; and performing individual chronic disease risk assessment based on the individual chronic disease composite interaction risk factor data to generate individual chronic disease risk assessment data. According to the invention, chronic disease health management and accurate evaluation are realized through collaborative evaluation work of chronic disease risks.
Owner:SHANDONG VICTOR INFORMATION TECH CO LTD

Flow cell devices and optical systems for in SITU nucleic acid sequencing

Fluorescence imaging systems designs, flow cell devices, and methods of are described herein that enable imaging of three or more axially displaced surfaces without using any optical compensators. The optical systems and flow cell devices herein provides higher throughput analysis for genomics and other imaging applications at a lower cost.
Owner:ELEMENT BIOSCIENCES INC

Machine learning architecture for modeling local and global features

Deep learning tools such as convolutional neural networks (CNNs) and transformers have spurred great advancements in computational biology. However, existing methods are constrained architecturally in context length, computational complexity, and model size. This application introduces a sub-quadratic architecture for modeling, which combines projected gated convolutions and structured state spaces to achieve local and global context with, for example, single-nucleotide resolution. These models outperform CNN-, GPT-, BERT-, and long convolution-based models in many tested genomics tasks without pre-training and with 4×-781× fewer parameters. In the proteomics domain, these models similarly outperform pretrained attention-based models, including ESM-1B and TAPE-BERT, on remote homology prediction without pre-training and while using 3,308×-23,636× fewer parameters.
Owner:MASSACHUSETTS INST OF TECH +2

Gene detection data cleaning method and system based on artificial intelligence

The invention relates to the technical field of genomics, in particular to a gene detection data cleaning method and system based on artificial intelligence. The method comprises the following steps: acquiring gene detection data, and performing preliminary filtering on the gene detection data based on removal of low-quality reads to obtain preliminary filtering data; performing linker sequence identification and removal on the preliminarily filtered data, and performing sequencing error correction to generate gene sequence data; performing GC content analysis and repetitive sequence identification on the gene sequence data to obtain sequence feature data; performing dynamic quality threshold adjustment according to the sequence feature data, and performing secondary filtering on the gene sequence data to generate high-quality sequence data; and performing sequence pattern recognition on the high-quality sequence data to obtain sequence pattern feature data. According to the method, deep analysis is carried out by utilizing sequence characteristics such as GC content and nucleotide distribution, and the recognition capability on sequence complexity and variation modes is improved.
Owner:SICHUAN BAIYUE BIOTECHNOLOGY CO LTD

Drug screening and disease model construction method for liver organoid

The invention provides a method for drug screening and disease model construction of liver organoid, relates to the technical field of medical research, and adopts multi-modal data acquisition, fusion and intelligent analysis and quantum computing processing to optimize comprehensive application of data, so that the richness, accuracy and analysis efficiency of the data are remarkably improved, and the risk of drug screening and disease model construction of liver organoid is reduced. Multi-source data of genomics, transcriptomics and the like are collected comprehensively, an accurate research system of immune-hepatic disease interaction based on organoid is constructed, an in-vivo complex immune-hepatic disease microenvironment can be highly simulated, the proportion and activation state of immune cells are accurately regulated and controlled in an in-vitro model, functional and phenotypic changes of the immune cells are monitored in real time, and the immune-hepatic disease interaction accuracy is improved. According to the present invention, the interaction mechanism between the immune cells and the liver organ cells is deeply revealed, such that the accurate information basis is provided for the accurate determination of the drug action target, the development of the innovative drug for the immune check point or tumor microenvironment regulation is easily achieved, and the pertinence and the success rate of the drug research and development are substantially improved.
Owner:TONGJI HOSPITAL ATTACHED TO TONGJI MEDICAL COLLEGE HUAZHONG SCI TECH

AA2CDS:Pre-trained Amino Acid-to-Codon Sequence Mapping Enabling Efficient Expression and Yield Optimization

Systems, methods, and apparatus for generating a DNA / gene sequence output, given a protein sequence input. In one aspect, the protein-to-DNA mapping system includes a protein language model (embedder) that generates a high-dimensional protein embedding from a low-dimensional protein sequence input; and the system includes a protein-to-DNA translator that processes the protein embedding and generates a DNA sequence output, based on the protein embedding. The protein-to-DNA translator is a neural network (e.g., a Seq2Seq model) and is configured with translation coefficients that may be trained with a training dataset, comprising the training protein and DNA embeddings. Training the translation coefficients can include supervised learning that maps the protein embedding (input) to a DNA sequence (target). The systems, methods, and apparatus may increase protein yield / expression, improve protein functionality, enhance gene therapy efficacy, streamline synthetic biology design, and / or broaden functional genomics studies, all leading to reduced costs, better performance, and increased accessibility.
Owner:PROTEINEA INC

SNP (Single Nucleotide Polymorphism) molecular marker located on porcine chromosome 14 and related to porcine reproductive traits and application of SNP molecular marker

The invention relates to the technical field of molecular biology and molecular markers, in particular to an SNP (Single Nucleotide Polymorphism) molecular marker located on a porcine chromosome 14 and related to porcine reproductive traits and application. The SNP site of the SNP molecular marker located on the No.14 chromosome of the pig and related to the reproductive traits of the pig corresponds to the Cgt at the 105043272th site on the No.14 chromosome of the international pig reference genome version 11.1; t mutation is carried out, and the polymorphism of the basic group at the site affects the porcine reproductive traits; wherein the reproductive performance of pigs with CC and TC genotypes is superior to that of pigs with TT genotypes. By optimizing the dominant alleles of the SNP molecular marker, the frequency of the dominant alleles can be increased generation by generation, the reproductive performance of pigs is improved, and the genetic improvement progress of the pigs is accelerated, so that the economic benefit of pig breeding is effectively improved.
Owner:SOUTH CHINA AGRICULTURAL UNIVERSITY

Prediction method and system for breast cancer immunohistochemical index and typing

The invention discloses a breast cancer immunohistochemical index and typing prediction method and system. The prediction method comprises the following steps: acquiring a breast ultrasound image and a breast magnetic resonance image of a patient; performing preprocessing and quality control on the mammary gland ultrasonic image and the mammary gland magnetic resonance image; performing breast lesion area segmentation by adopting a deep learning model to obtain segmented lesion areas; based on the segmented lesion area, extracting multi-modal radiomics characteristics of the breast ultrasonic image and the breast magnetic resonance image; fusing the multi-modal radiomics characteristics of the breast ultrasound image and the breast magnetic resonance image, constructing a machine learning model, and performing immunohistochemical index prediction to obtain an immunohistochemical index prediction result; and performing breast cancer molecular typing analysis according to the immunohistochemical index prediction result. By fusing the multi-modal image information, the tumor features can be described more comprehensively, and the accuracy of biomarker prediction is improved.
Owner:PEKING UNIVERSITY THIRD HOSPITAL (THE THIRD CLINICAL MEDICAL SCHOOL OF PEKING UNIVERSITY)

Multi-omic assessment using proteins and nucleic acids

Described herein are methods such as multi-omic methods for assessing a disease such as cancer. The multi-omic methods may integrate proteomic, transcriptomic, genomic, lipidomic, or metabolomic data. The method screening diseases or disease states. Also described herein are methods for screening for diseases or disease states from biological samples. The methods may include assessing whether a nodule, mass, or cyst is cancerous.
Owner:PROGNOMIQ INC

Tumor recurrence risk assessment and early warning system based on data analysis

The invention discloses a tumor recurrence risk assessment and early warning system based on data analysis, and belongs to the technical field of medical information. The invention discloses a tumor recurrence risk assessment and early warning system based on data analysis. The system comprises a multi-data collection module, a big data processing platform, a model architecture system and an individual data processing system. According to the invention, the problems of lack of big data support, limited individualized prediction ability and insufficient real-time performance and continuous monitoring in the prior art are solved; according to the method, large-scale historical case data are integrated, the rich data sets are used for model training, the accuracy and generalization ability of a prediction model can be remarkably improved, multiple data sources such as genomics information, living habits and environmental factors are integrated, personalized risk assessment is provided for each patient, and the risk assessment efficiency is improved. The real-time monitoring interface is connected with various intelligent medical devices to collect the daily physiological parameter change condition of the patient, and continuous health management suggestions are provided for the tumor postoperative patient.
Owner:JIANGNAN UNIV

Genomics cross-modal condition generation method and system based on potential diffusion model

The invention discloses a genomics cross-modal condition generation method and system based on a potential diffusion model, and belongs to the field of bioinformatics, and the method comprises the following steps: respectively designing and constructing an auto-encoder for gene expression and gene mutation data, and carrying out model training; constructing a potential feature space according to an encoder of gene mutation data and training an unconditionally guided potential diffusion model; constructing a cross-modal feature alignment network according to the two trained encoders and training the cross-modal feature alignment network; and performing joint fine tuning on the unconditionally guided potential diffusion model and the cross-modal feature alignment network. According to the method, the problem of sample modal deletion in multi-modal learning is solved, potential correlation between gene expression data and gene mutation data can be captured through cross-modal feature alignment, information flow between different modals is enhanced, and high-quality prediction data is effectively generated when mutation data is deleted through the potential diffusion model.
Owner:ZHEJIANG LAB

Combined element for screening aptamer and use thereof, and high-throughput screening method for aptamer

A high-throughput screening method for an aptamer, and a use. An implementation route is divided into three parts, a first part is construction of a library of a pre-enriched aptamer and sequencing same, a second part is generation of an aptamer cluster on a slide, and a third part is combination of a target protein and the aptamer cluster. Provided is a method for high-throughput rapid detection of an aptamer. The method has the beneficial effects: sequencing time, sequence synthesis and affinity re-verification time are saved, the affinity verification costs are greatly saved, rapid screening of aptamers can be promoted, and the actual use of aptamers is promoted along with the increase in the types and numbers of aptamers. The existing platform BGISEQ 500 of Beijing Genomics Institute can be used to grow an aptamer cluster on a chip by using DNB as a template, and the use of sequencers is expanded by integrating sequencing, sequence synthesis and affinity identification.
Owner:SHENZHEN HUADA GENE INST

Multi-omics evaluation

Methods for assessing disease, such as multi-omics methods, are described herein. A multi-omics method can integrate proteomic data, transcriptomic data, genomic data, lipidomic data, or metabonomic data. The method screens for a disease or a disease state. Also described herein are methods of screening a disease or a disease state from a biological sample. Multi-omics databases and methods of using them are also described herein.
Owner:PROTEC CO LTD

Lymphoma prognosis prediction method and device based on PET-CT marker and medium

The invention relates to a lymphoma prognosis prediction method and device based on a PET-CT marker and a medium, and the method comprises the following steps: obtaining a PET / CT image of a patient, inputting the PET / CT image into a lymphoma prognosis prediction model based on image-clinical-molecular typing, and obtaining a prognosis risk category; the lymphoma prognosis prediction model based on image-clinical-molecular typing is constructed according to PET-CT markers, clinical indexes and genetic typing data, the PET-CT markers are obtained by calculating a segmentation result of a PET / CT image of a patient according to a bimodal lesion segmentation network, and prognosis significance verification is performed through a K-M survival curve; the bimodal lesion segmentation network comprises an encoder and a decoder, the encoder performs feature extraction through a plurality of convolutional layers, and a channel smoothing layer is introduced after the last convolutional layer to fuse the extracted features. Compared with the prior art, tumor information can be accurately captured from PET / CT images, and lymphoma prognosis prediction is carried out in combination with genomics and clinical medicine.
Owner:RUIJIN HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE

Integration of radiologic, pathologic, and genomic features for prediction of response to immunotherapy

Presented herein are systems, methods, and non-transient computer readable media for determining predicted response scores of subjects. A computing system may identify a first feature set for a first subject to be administered with immunotherapy to address a condition. The first feature set may include one or more of: (i) a first radiological feature identified in a tomogram of a section associated with the condition in the first subject, (ii) a first immunohistochemistry (IHC) feature derived from an image of a sample associated with the first subject, and (iii) a first genomic feature obtained from gene sequencing of the first subject for genes associated with the condition. The computing system may apply the first feature set to a model. The computing system may determine, from applying the first feature set to the model, a predicted score identifying a response to the immunotherapy to be administered to the first subject.
Owner:MEMORIAL SLOAN KETTERING CANCER CENT +2

Method for regulating and controlling gene expression of lactic acid bacteria in shrimp acid fermentation based on systematic biology

The invention relates to a method for regulating and controlling gene expression of lactic acid bacteria in shrimp acid fermentation based on systematic biology. The method comprises the following steps: constructing a gene regulation network of lactic acid bacteria by using whole genome data and a high-throughput sequencing technology comprising RNAseq; through clustering analysis and network reconstruction, transcription factors and enzymes of key metabolic pathways of lactic acid generation, acid resistance and glycometabolism are identified, and a dynamic regulation and control model of gene expression is established; a GeneNet or Cytoscape software tool is used, genomics, transcriptomics and metabonomics data of lactic acid bacteria are fused in a multi-layer network, a metabolism regulation and control system is constructed, and the metabolism regulation and control system comprises gene expression regulation and control and real-time change of metabolic flow; the method comprises the following steps: constructing a metabolic flux dynamic model of lactic acid bacteria based on a metabolic flux analysis MFA and a dynamic system modeling technology, and analyzing a mutual relation between a lactic acid generation path and a byproduct generation path; fBA is analyzed through flow equilibrium, and the metabolic network of lactic acid bacteria is optimized.
Owner:GUIZHOU PROVINCIAL MODERN AGRI DEV RES INST (GUIZHOU PROVINCIAL MODERN RURAL DEV RES CENT GUIZHOU PROVINCIAL RES INST OF RURAL ECONOMIC & SOCIAL DEV GUIZHOU PROVINCIAL AGRI PROD PROCESSING RES INST)

Cancer subtype classification method based on KAN network and multi-omics data

The invention provides a cancer subtype classification method based on a KAN network and multi-omics data, and the method comprises the steps: obtaining the multi-omics data, including genomics data, transcriptomics data and proteomics data, and constructing a test data set; carrying out feature extraction and integration on the multi-omics data by utilizing a Colmogolov-Arnod network model, and carrying out training to obtain a trained cancer typing model; in the model evaluation stage, a Monte Carlo discarding method is adopted to carry out multiple times of forward propagation so as to estimate the uncertainty of a model prediction result and improve the robustness of the model; and carrying out cancer typing prediction, and carrying out high-precision cancer typing on multi-omics data by using the trained Colmogolov-Arnod network model. According to the method, the problem of heterogeneity of multi-omics data can be effectively solved, the accuracy and robustness of cancer typing are improved, and the effect of personalized treatment is improved.
Owner:XIAMEN UNIV OF TECH

Bioinformatics Systems, Apparatuses, and Methods for Performing Secondary and / or Tertiary Processing

A system, method and apparatus for executing a bioinformatics analysis on genetic sequence data is provided. Particularly, a genomics analysis platform for executing a sequence analysis pipeline is provided. The genomics analysis platform includes one or more of a first integrated circuit, where each first integrated circuit forms a central processing unit (CPU) that is responsive to one or more software algorithms that are configured to instruct the CPU to perform a first set of genomic processing steps of the sequence analysis pipeline. Additionally, a second integrated circuit is also provided, where each second integrated circuit forming a field programmable gate array (FPGA), the FPGA being configured by firmware to arrange a set of hardwired digital logic circuits that are interconnected by a plurality of physical interconnects to perform a second set of genomic processing steps of the sequence analysis pipeline, the set of hardwired digital logic circuits of each FPGA being arranged as a set of processing engines to perform the second set of genomic processing steps. A shared memory is also provided.
Owner:ILLUMINA INC

Systems and methods for multimodal large language machine learning models with integrated checker for unvalidated responses

Systems and methods for analyzing multimodal data using one or more large language machine learning models may include inputting medical image data to a trained image-based machine learning model and generating medical image data embeddings; inputting genomic data to a trained genomics machine learning model and generating genomic data embeddings; inputting text data to a trained large language machine learning model, and generating a mapping of extruded data; and feeding the medical image data embeddings, the genomic data embeddings, and the mapping of extruded data to trained large language machine learning model at a foundation layer, the trained large language machine learning model at the foundation layer being trained to generate one or more of a data and analytics report, a diagnostic analysis report, a large language model agent, or user data for display in a user interface at an output device.
Owner:MAYO FOUNDATION FOR MEDICAL EDUCATION & RESEARCH

Methods for predicting relative benefit of therapy options and devices thereof

Methods, non-transitory computer-readable media, and devices are disclosed that identify and validate a signature for predicting relative benefit of two therapies for frontline and therapy sequencing for patients. Described and illustrated by way of the example herein are machine learning approaches for gaining data-driven insights from the mutational landscape in metastatic pancreatic adenocarcinoma (mPDAC) and validating the signature in predicting relative benefit from FOLFIRINOX (FFX) and Gemcitabine / nab-Paclitaxel (GA) therapies. This technology inputs a patient's genomics findings and clinical data and generates predictions of relative effectiveness for the two distinct FFA and GA chemotherapy options. The predictions for an individual patient provide personalized guidance on treatment sequencing to improve patient health outcomes.
Owner:PERTHERA INC

Liquid drop positioning printing method and single cell analysis platform

The invention provides a liquid drop positioning printing method and a single cell analysis platform, and the method is used for calibrating the position of a nozzle before liquid drop printing, and comprises the following steps: pre-printing a plurality of liquid drops on a base material by using at least two specified nozzles, and obtaining the position of a pre-printed liquid drop point; and correcting the theoretical value coordinate of the nozzle position based on the drop point position to obtain a correction value coordinate of the nozzle position. According to different types of printing heads, high-efficiency and high-precision liquid drop arrangement operation can be completed under different liquid and different printing conditions, so that high-throughput and high-accuracy single cell operation can be completed by utilizing the single cell sorting device. The single cell analysis platform comprises a control assembly, a single cell sorting and printing device, a dielectric wetting chip and an optical module, and can realize pretreatment of single cell capture, fixation, dyeing and the like on a micro platform at a micron-to-millimeter level, so as to realize high-throughput analysis of cell morphology, genomics, transcriptomics and proteomics.
Owner:SHANGHAI AUREFLUIDICS TECH CO LTD

High-throughput single-cell multi-omics three-dimensional genome detection method and system

The invention provides a high-throughput single-cell multi-omics three-dimensional genome detection method and system. The detection method comprises the following steps: enzyme digestion reaction of fixed cells; carrying out proximity ligation treatment on the cells subjected to the enzyme digestion reaction; carrying out analysis treatment including reverse transcription on the treated cells, and respectively constructing a DNA library and an RNA library; and sequencing to obtain three-dimensional genomics information in a single cell. A high-throughput single-cell multi-omics three-dimensional genomics detection technology is designed, chromatin in cells is subjected to opening treatment through different methods, chromatin opening sites are enriched, the throughput of generated data is greatly improved, and the detection accuracy is greatly improved while the chromatin openness is detected in a single cell. The capability of detecting interaction between chromatin open sites and the gene expression capability are improved.
Owner:ZHEJIANG UNIV

Single bacterium separation method based on digital microfluidic system and application

The invention relates to a single bacterium separation method based on a digital micro-fluidic system, which comprises the following steps: injecting diluted bacterium liquid into a digital micro-fluidic chip to form bacterium liquid drops with 2 < N > power as electrode bases, and distributing 18-22 bacteria per 64 electrode bases in each bacterium liquid drop; the liquid drops with the same volume are controlled to move in the opposite direction, and half-and-half tearing is carried out; according to the mode, the liquid drops after half-and-half tearing are subjected to half-and-half tearing again, N rounds are carried out in total, and 2 < N > single-electrode liquid drops are formed; the single bacterium liquid drops are obtained. The separation method has the advantages that the separation efficiency is high, the separation speed is high, the separation flux is high, and the final separation success rate can reach 100%, and the single-bacterium separation method can be well applied to bacterium culture, polypeptide drug or antibody screening and genomics analysis in a digital microfluidic system.
Owner:GUANGDONG ACXEL MICRO & NANO TECH CO LTD

Method and system for managing medical health care records of user

The invention relates to the technical field of health management, and discloses a method and system for managing medical health care records of a user, and the method comprises the following steps: S1, collecting multi-modal medical data of the user, including electronic health records, medical image data, vital sign data and genomics data; s2, preprocessing the collected medical data, including data cleaning, format standardization and noise removal; and S3, carrying out time synchronization on the data of different modalities by adopting an optimized time alignment method. According to the method, probability modeling and topological data analysis are adopted, the health prediction precision is improved, false alarms and missing alarms are reduced, federated learning and differential privacy are combined, cross-mechanism collaborative modeling is achieved, data safety is enhanced, health intervention is optimized through reinforcement learning, a management strategy is dynamically adjusted, and the individuation precision is improved; the scheme has better adaptability, safety and intelligence.
Owner:NANFANG HOSPITAL OF SOUTHERN MEDICAL UNIV

Super-resolved object detection with spatial genomics

The present disclosure provides methods for encoding and decoding signals from barcodes in a plurality of molecular targets from images obtained from imaging based spatial genomics (ISG) experiments. This disclosure sets forth methods, in addition to use of the same, and other solutions to problems in the relevant field.
Owner:CALIFORNIA INST OF TECH

AI prediction system for relapse after radiotherapy of local advanced rectal cancer

The invention relates to the technical field of clinical medicine, and discloses an AI prediction system for relapse after radiotherapy of local advanced rectal cancer, and the system comprises a multi-modal biological image database building module which is used for collecting clinical data, image data, radiotherapy target region and dose distribution data, radiobiological data and genomics information of a patient, integrating the data to establish a database; a feature extraction and screening module; a prediction model construction module; a model verification and optimization module; and a clinical application evaluation module. According to the invention, information of patients in multiple aspects such as clinic, image, radiotherapy target area and dose distribution, radiobiology and genomics is widely collected, and the multi-modal biological image database is integrated and established, so that various factors influencing rectum cancer relapse after radiotherapy can be comprehensively covered; a rich, accurate and comprehensive data basis is provided for subsequent accurate analysis and prediction, and the accuracy and reliability of prediction of relapse conditions after radiotherapy are improved.
Owner:CHINESE PEOPLES LIBERATION ARMY ARMY SPECIAL MEDICAL CENTER

Method and system for predicting venous thromboembolism risk of lung cancer patient

The invention relates to the field of medical information technology and medical data analysis, in particular to a VTE risk prediction method and system based on multi-modal data fusion and dynamic risk modeling, and the system comprises a first feature extraction module, a second feature extraction module, a two-stage risk assessment module and a final risk judgment module. According to the application, through integration of clinical diagnosis and treatment, iconography and genomics data, a deep learning algorithm, a dynamic weight adjustment mechanism and a graph neural network technology are utilized to realize accurate prediction of the VTE risk of the active-stage lung cancer patient. And meanwhile, the problem of cross-mechanism data distribution difference is solved by adopting transfer learning, and the generalization ability of the model is improved. The method can significantly improve the prediction accuracy, reduces the manual intervention demands, and optimizes the medical resource distribution efficiency.
Owner:CHINA JAPAN FRIENDSHIP HOSPITAL

II-B type endonuclease mediated gene editing system and application

PendingCN119040297AHas targeted editing activityHydrolasesNucleic acid vectorGenomicsBase J
The invention discloses a II-B type endonuclease mediated gene editing system and application, and particularly relates to a Gs9-1 nuclease belonging to a II-B type Cas9 family identified by utilizing metagenomics in combination with experiments, and the Gs9-1 nuclease identifies a PAM sequence containing NGG and guides RNA (sgRNA) through a specific skeleton sequence. The invention also establishes a genome targeted editing technology based on Gs9-1 nuclease mediation, and has wide application prospects in the technical fields of accurate modification of genome sequences and induction of insertion, deletion or base substitution in genomes.
Owner:HUAZHONG AGRI UNIV +1

System and method for predicting effective and safe drug therapy

PCT designated stageWO2025217460A1Medical data miningHealth-index calculationGenomicsDrug profile
Various methods and systems for efficiently providing pharmacogenetic guidelines is disclosed. A drug prescription and a patient genotype can be analyzed to provide a drug therapy recommendation. The analysis can include comparing the patient genotype and the drug name to a drug profile database, a molecular biomarker database, hospital drug reaction records and omics databases, and calculating the patient response to the drug.
Owner:PGXAI INC